International audienceIn the current study, twenty-two compounds based upon 3-hydroxy-3-(2-oxo-2-phenylethyl)indolin-2-one nucleus were designed, synthesized and in vitro evaluated for HIV-1 RT inhibition and anti-HIV-1 activity. Compounds 3d, 5c and 5e demonstrated encouraging potency against RT enzyme as well as HIV-1 in low micromolar to nanomolar concentration with good to excellent safety index. Structure activity relationship studies revealed that halogens such as bromo or chloro at 5th the position of oxindole ring remarkably enhanced the potency against RT. Moreover, methoxy or chloro groups at the ortho position of phenyl ring also significantly favored RT inhibition activity. Seven compounds (3b, 3c, 3d, 3e, 5b, 5c and 5e) with be...
Seven novel N-arylsulfonyl-3-(2-yl-ethanone)-6-methylindole derivatives 4a–f and 6 were readily synt...
Indolyl aryl sulfones bearing the 4,5-difluoro (10) or 5-chloro-4-fluoro (16) substitution pattern a...
In the effort to identify and develop new HIV-1 inhibitors endowed with innovative mechanisms, we fo...
International audienceIn the current study, twenty-two compounds based upon 3-hydroxy-3-(2-oxo-2-phe...
The heterocyclic indole structure has been shown to be one of the most promising scaffolds, offering...
Objective: Acquired immunodeficiency syndrome (AIDS) was first identified in the Western world in 19...
Molecular modeling studies and an updated highly predictive 3-D QSAR model led to the discovery of e...
Molecular modeling studies and an updated highly predictive 3-D QSAR model led to the discovery of e...
A novel oxindole was discovered as an HIV non-nucleoside reverse transcriptase inhibitor via HTS usi...
Compound 1 (VEC-5) was identified as a potent small-molecular HIV-1 viron infectivity factor inhibit...
The potent anti-HIV-1 activities of L-737,126 (2) and PAS sulfones prompted us to design and test ag...
Indolyl aryl sulphones (IASs) are a potent class of HIV-1 non-nucleoside reverse transcriptase inhib...
The HIV-1 viral infectivity factor (VIF) protein is essential for viral replication. VIF recruits ce...
New non-nucleoside reverse transcriptase inhibitors (NNRTIs) that are active against the commonly oc...
New indolylarylsulfone derivatives bearing cyclic substituents at indole-2-carboxamide linked throug...
Seven novel N-arylsulfonyl-3-(2-yl-ethanone)-6-methylindole derivatives 4a–f and 6 were readily synt...
Indolyl aryl sulfones bearing the 4,5-difluoro (10) or 5-chloro-4-fluoro (16) substitution pattern a...
In the effort to identify and develop new HIV-1 inhibitors endowed with innovative mechanisms, we fo...
International audienceIn the current study, twenty-two compounds based upon 3-hydroxy-3-(2-oxo-2-phe...
The heterocyclic indole structure has been shown to be one of the most promising scaffolds, offering...
Objective: Acquired immunodeficiency syndrome (AIDS) was first identified in the Western world in 19...
Molecular modeling studies and an updated highly predictive 3-D QSAR model led to the discovery of e...
Molecular modeling studies and an updated highly predictive 3-D QSAR model led to the discovery of e...
A novel oxindole was discovered as an HIV non-nucleoside reverse transcriptase inhibitor via HTS usi...
Compound 1 (VEC-5) was identified as a potent small-molecular HIV-1 viron infectivity factor inhibit...
The potent anti-HIV-1 activities of L-737,126 (2) and PAS sulfones prompted us to design and test ag...
Indolyl aryl sulphones (IASs) are a potent class of HIV-1 non-nucleoside reverse transcriptase inhib...
The HIV-1 viral infectivity factor (VIF) protein is essential for viral replication. VIF recruits ce...
New non-nucleoside reverse transcriptase inhibitors (NNRTIs) that are active against the commonly oc...
New indolylarylsulfone derivatives bearing cyclic substituents at indole-2-carboxamide linked throug...
Seven novel N-arylsulfonyl-3-(2-yl-ethanone)-6-methylindole derivatives 4a–f and 6 were readily synt...
Indolyl aryl sulfones bearing the 4,5-difluoro (10) or 5-chloro-4-fluoro (16) substitution pattern a...
In the effort to identify and develop new HIV-1 inhibitors endowed with innovative mechanisms, we fo...